ugli
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
|
ugli [2023/11/10 13:53] sylvia [UGLI Release 2] |
ugli [2023/11/22 10:55] (current) sylvia [UGLI Release 2] |
||
|---|---|---|---|
| Line 91: | Line 91: | ||
| ===== UGLI Release 2 ===== | ===== UGLI Release 2 ===== | ||
| - | As of March 2023, data of an additional 28,250 genotyped participants has been made available. Samples in this release, called UGLI2, were genotyped using the FinnGen Thermo Fisher Axiom® custom array. | + | As of March 2023, data of an additional 28,249 genotyped participants has been made available. Samples in this release, called UGLI2, were genotyped using the FinnGen Thermo Fisher Axiom® custom array. |
| 29,166 participants were selected for UGLI 2 release and assessed using the pre mentioned array. All genotypes were included for QC screening, but the QC focussed on the the autosomes and chromosomes X for which there are N=617,715 and 22,405 markers available, respectively. A final set of 28,250 samples and 462,731 markers on autosomal and X chromosomes passed the QC steps described in | 29,166 participants were selected for UGLI 2 release and assessed using the pre mentioned array. All genotypes were included for QC screening, but the QC focussed on the the autosomes and chromosomes X for which there are N=617,715 and 22,405 markers available, respectively. A final set of 28,250 samples and 462,731 markers on autosomal and X chromosomes passed the QC steps described in | ||
ugli.1699620831.txt.gz · Last modified: 2023/11/10 13:53 by sylvia
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
